Pacific Biosciences
PACB
PACB
99 hedge funds and large institutions have $331M invested in Pacific Biosciences in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 101 → 99 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
63% less call options, than puts
Call options by funds: $182K | Put options by funds: $495K
Holders
99
Holding in Top 10
2
Calls
$182K
Puts
$495K
Top Buyers
| 1 | +$7.23M | |
| 2 | +$3.74M | |
| 3 | +$3.02M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
Top Sellers
| 1 | -$6.8M | |
| 2 | -$6.08M | |
| 3 | -$3.27M | |
| 4 |
TA
Teachers Advisors
New York
|
-$2.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.14M |